Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Reflexion Medical, Inc.: RefleXion X1 Radiotherapy System Recalled for Potential Radiation Dose Errors

Agency Publication Date: May 30, 2024
Share:
Sign in to monitor this recall

Summary

Reflexion Medical, Inc. has recalled 7 units of the RefleXion X1 Radiotherapy System (Model RXM1000) running software version 2.1.19-3. This specialized system, which combines imaging with a linear accelerator, has a software defect that can cause a potential dose error for patients receiving specific radiotherapy treatments. The issue occurs when patients are treated with an 'out of session SCINTIX partial fraction,' which could result in the patient receiving an incorrect amount of radiation during their therapy session. These systems were distributed in California, Connecticut, New Jersey, Oregon, Pennsylvania, and Texas.

Risk

The software defect may lead to patients receiving an incorrect dose of radiation during treatment. Inaccurate radiation delivery can compromise the effectiveness of cancer treatment or cause unintended exposure to healthy tissues, potentially leading to treatment complications.

What You Should Do

  1. Identify if your facility uses the RefleXion X1 Radiotherapy System Model RXM1000 with software version 2.1.19-3.
  2. Check the system's serial number against the affected list: X11001, X11002, X11003, X11004, X11006, X11007, or X11008.
  3. Healthcare providers should immediately contact Reflexion Medical, Inc. for technical guidance regarding software version 2.1.19-3 and to discuss necessary precautions for SCINTIX partial fraction treatments.
  4. Patients who have received radiotherapy on this system should contact their radiation oncologist or healthcare provider to discuss their treatment plan and address any concerns regarding dose accuracy.
  5. For further technical assistance or information regarding potential refunds or software updates, contact Reflexion Medical, Inc. at their Hayward, California headquarters at 25881 Industrial Blvd, Hayward, CA 94545-2991.
  6. For additional information, contact the FDA Medical Device recall line at 1-888-463-6332 or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Manufacturer Notification and Technical Guidance

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: RefleXion X1 Radiotherapy System Model RXM1000 (Software version 2.1.19-3)
Model / REF:
RXM1000
Lot Numbers:
X11001
X11002
X11003
X11004
X11006
X11007
X11008

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94533
Status: Active
Manufacturer: Reflexion Medical, Inc.
Sold By: Authorized medical distributors
Manufactured In: United States
Units Affected: 7 systems
Distributed To: California, Connecticut, New Jersey, Oregon, Pennsylvania, Texas

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.